Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2023
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/18736 |